2022 Speakers

Thorsten Graef

CMO

Acepodia

Don Healey

Chief Technology Officer

Adicet Bio

Blake Aftab

Chief Scientific Officer

Adicet Bio

Arndt Schottelius

Chief Scientific Officer

Affimed

Abhishek Srivastava

Senior Director Immunology

Athenex

Heather Raymon

Vice President Early Development & Program Management

Artiva Bio

Emily Wilkinson

Beacon Adoptive Cell Lead Research Analyst

Beacon

Debora Barton

Chief Medical Officer

Carisma Therapeutics

Joseph Gold

VP Technical Operations

Catamaran Bio

Nicholas Boyd

CDO

Cartherics

Bradley Glover

EVP & Chief Technology Officer

Celularity

Jennifer Dashnau

Head of Analytical Development & Quality Control

Century Therapeutics

Christina Coughlin

CEO

Cytoimmune

Daniel Teper

CEO

Cytovia Therapeutics

Melody Eble

Vice President Global Regulatory Affairs

Century Therapeutics

Stanley Frankel

Chief Medical Officer

Cytovia Therapeutics

Wei Li

Chief Scientific Officer

Cytovia Therapeutics

Rizwan Romee

Associate Professor of Medicine

Dana-Farber Cancer Institute

Jode Goodridge

Associate Director

Fate Therapeutics

Gregory Fiore

CEO

Exacis Biosciences

Raedun Clarke

Director Process Development

Fate Therapeutics

Yoshikazu Yonemitsu

Chief Scientific Officer & Chief Technology Officer

Gaia BioMedicine

Oliver Nussbaumer

VP Immunology

Gammadelta Therapeutics

Marcel Zwaal

CEO

Gadeta

Volker Huppert

CDO

glycostem

Michael DeRidder

VP Medicine Commercialization Leader, Oncology Cell Therapy

GSK

Jan Spanholtz

CSO

glycostem

Austin Bigley

VP Research & Development

Indapta Therapeutics

Kate Rochlin

VP Operations & Innovations

IN8bio

Uriel Moreno

Scientist

Johnson & Johnson

Hans-Gustaf Ljunggren

Professor

Karolinska Institutet

Evren Alici

Head of Cell & Gene Therapy Group

Karolinska Institutet

Nicholas Huntington

Professor Biochemistry & Molecular Biology

Monash University

Emily Levy

Senior Scientist

Merck

Kimberly Schluns

Senior Director Research

Kite: A Gilead Company

James Trager

Chief Scientific Officer

NKarta

Stephen Chen

Chief Technology Officer

NKGen Biotech

Kanya Rajangam

Chief Medical Officer

NKarta Therapeutics

Ralph Brandenberger

SVP Tech Ops

NKarta Therapeutics

Christopher Nowers

CEO

ONK Therapeutics

Mary Reilly

Chief Operating Officer

ONK Therapeutics

Michael O’Dwyer

Founder & CSO

ONK Therapeutics

Stacey Cranert

Associate Director Research Immuno-Oncology

Poseida Therapeutics

Amy Sharma

Director Regulatory Toxicity, Strategy Lead Drug Safety R&D

Pfizer

Robert Igarashi

Vice President Discovery & Preclinical Development

Sanofi

Marcia Blackmoore

CMC Project Leader, Genomic Medicines Unit

Sanofi

Andre Kunert

Principal Scientist

Sanofi

Alba Gonzalez

Director of Research

Senti Biosciences

Daniel Kaufman

Co-Founder & CSO

Shoreline Biosciences

Gary Lee

Chief Scientific Officer

Senti Biosciences

Philip Lee

Chief Technology Officer

Senti Biosciences

Aman Singh

Associate Director Clinical Pharmacology M&S, Cell Therapy

Takeda

Anahid Jewett

Professor & Director Tumor Immunology Laboratory

UCLA

Beau Webber

Assistant Professor

University of Minnesota

Emily Mace

Assistant Professor of Pediatric Immunology

University of British Columbia

Jeffrey Miller

Professor of Medicine

University of Minnesota

Branden Moriarity

Principal Investigator

University of Minnesota

Caimei Zhang

Senior Research Investigator

University of Pennsylvania

Neil Sheppard

Adjunct Associate Professor

University of Pennsylvania

Christian Capitini

Associate Professor, Pediatrics

University of Wisconsin-Madison

Ayman Kabakibi

Chief Operating Officer

Wugen

Dan Kemp

CEO

Wugen

Michael Uhlin

Chief Scientific Officer

XNK Therapeutics

Todd Fehniger

Professor of Medicine

Washington University School of Medicine, St. Louis

Anders Holm

Chief Operating Officer

Zelluna Immunotherapy